2004
DOI: 10.1074/jbc.m408495200
|View full text |Cite
|
Sign up to set email alerts
|

SH2-B Promotes Insulin Receptor Substrate 1 (IRS1)- and IRS2-mediated Activation of the Phosphatidylinositol 3-Kinase Pathway in Response to Leptin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
127
0
1

Year Published

2006
2006
2017
2017

Publication Types

Select...
4
4

Relationship

2
6

Authors

Journals

citations
Cited by 145 publications
(129 citation statements)
references
References 49 publications
1
127
0
1
Order By: Relevance
“…This association may be attributable, however, to the effects of the polymorphism on the neuroendocrine systems, given that neuroendocrine disorders can result in a decrease in the concentration of growth hormone and sex steroids and thus accelerate the development of osteoporosis (24). SH2B1 is a widely-expressed cytoplasmic protein that simultaneously binds, via its Src homology 2 (SH2) domain, to both Janus kinase 2 (JAK2) and insulin receptor substrate 2 (IRS2), thereby promoting the leptin-induced activation of the phosphoinositide 3-kinase signaling pathway in cultured cells (25,26). SH2B1-deficient mice develop insulin resistance and type 2 diabetes mellitus (27) as well as severe leptin resistance, hyperphagia and obesity (28).…”
Section: Discussionmentioning
confidence: 99%
“…This association may be attributable, however, to the effects of the polymorphism on the neuroendocrine systems, given that neuroendocrine disorders can result in a decrease in the concentration of growth hormone and sex steroids and thus accelerate the development of osteoporosis (24). SH2B1 is a widely-expressed cytoplasmic protein that simultaneously binds, via its Src homology 2 (SH2) domain, to both Janus kinase 2 (JAK2) and insulin receptor substrate 2 (IRS2), thereby promoting the leptin-induced activation of the phosphoinositide 3-kinase signaling pathway in cultured cells (25,26). SH2B1-deficient mice develop insulin resistance and type 2 diabetes mellitus (27) as well as severe leptin resistance, hyperphagia and obesity (28).…”
Section: Discussionmentioning
confidence: 99%
“…Among those, SH2B1 encodes a Src homology adaptor protein involved in leptin and insulin signaling. 25,26 Common variants near this locus are associated with BMI, serum leptin, and body fat in genome-wide association studies (GWASs), [27][28][29][30] while rare dominant mutations have been reported to cause obesity, social isolation, aggressive behavior, and speech and language delay. 31 None of the CNV-contained genes have been associated with ASD or HC defects.…”
Section: Introductionmentioning
confidence: 99%
“…SH2B1 C-terminal SH2 domain binds to phosphoTyr 813 in JAK2 as discussed above; in contrast, its N-terminal region binds to different sites on JAK2 in a tyrosine phosphorylation-independent manner [43] . Similarly, SH2B1 binds to phospho-tyrosine(s) of IRS1 or IRS2 via its SH2 domain, and binds to other sites on IRS proteins via its PH domain-containing regions in a tyrosine phosphorylation-independent fashion [46] . SH2B1 forms homodimers or oligomers via its N-terminal domains [15][16][17] .…”
Section: Sh2b1 Mediates/modulates Leptin Signalingmentioning
confidence: 99%
“…Genetic deletion of IRS2 in LEPR-expressing cells results in leptin resistance and obesity in mice [45] . SH2B1 directly binds to both IRS1 and IRS2 in addition to JAK2 [46] . In response to leptin, SH2B1 recruits IRS proteins to JAK2, thus allowing JAK2 to phosphorylate IRS proteins on tyrosine residues [46] .…”
Section: Sh2b1 Mediates/modulates Leptin Signalingmentioning
confidence: 99%
See 1 more Smart Citation